Mml Investors Services, LLC Cor Medix Inc. Transaction History

Mml Investors Services, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$3.6 - $4.46 $1,800 - $2,230	-500 Reduced 4.35%	11,000 $41,000
Q2 2023 Aug 14, 2023	SELL	$3.94 - $5.8 $51,220 - $75,400	-13,000 Reduced 53.06%	11,500 $46,000
Q1 2023 May 12, 2023	BUY	$3.22 - $4.61 $78,890 - $112,945	24,500 New	24,500 $101,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.